Cite
HARVARD Citation
Permuth‐Wey, J. et al. (n.d.). STAT3 polymorphisms may predict an unfavorable response to first‐line platinum‐based therapy for women with advanced serous epithelial ovarian cancer. International journal of cancer. 138 (3), pp. 612-619. [Online].